Prescription medicine
Tetradecyl hydrogen Brand names: Sotradecol
Tetradecyl hydrogen (Sotradecol) is a prescription medicine. FDA's NDC Directory lists it from 2 generic labelers.
- Generic listed
Check it at the source: the tetradecyl hydrogen FDA label on DailyMed (effective August 17, 2021, Mylan Institutional LLC); every tetradecyl hydrogen label on DailyMed.
Highlights of the record
FDA label of August 17, 2021; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026
Used for
From the label: indications and usageSotradecol (sodium tetradecyl sulfate injection) is indicated in the treatment of small uncomplicated varicose veins of the lower extremities that show simple dilation with competent valves.
Forms and strengths
- 10 mg/ml
- 30 mg/ml
Injection (solution).
On the market
- Generic approvals
- No generic approved
- Labelers listed (NDC)
- 2 of which 2 under generic applications, 0 under brand applications, repackagers included
Supply and safety
- Pharmacy cost (NADAC)
- Not in the survey
- Shortage (FDA)
- No current entry
- Recalls by its makers (FDA)
- No recall recorded
- FAERS reports
- 138 through July 30, 2026
What is tetradecyl hydrogen used for?
From the label: indications and usageSotradecol (sodium tetradecyl sulfate injection) is indicated in the treatment of small uncomplicated varicose veins of the lower extremities that show simple dilation with competent valves. The benefit-to-risk ratio should be considered in selected patients who are great surgical risks.
Source: FDA drug label (Sotradecol), Mylan Institutional LLC, effective August 17, 2021 (SPL set f1756c28-dcd2-4b49-be62-07ca20682018), via openFDA; the full label on DailyMed
Is there a generic for tetradecyl hydrogen (Sotradecol)?
No generic tetradecyl hydrogen is approved (Drugs@FDA, October 8, 2026).
FDA's NDC Directory lists tetradecyl hydrogen from 2 labelers under a generic (ANDA) application. A listing means the company has registered the product for sale; it does not show that every pharmacy stocks it.
Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)
What does the tetradecyl hydrogen label say about other medicines?
The tetradecyl hydrogen label names 2 other medicines in its interaction, contraindication or warning sections. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.
| Medicine named | Section | What the label says |
|---|---|---|
| Heparin | drug interactions | The physician must use judgment and evaluate any patient taking antiovulatory drugs prior to initiating treatment with Sotradecol. (See ADVERSE REACTIONS section.) Heparin should not be included in the same syringe as Sotradecol, since the two are incompatible. |
| Sodium tetradecyl | contraindications | CONTRAINDICATIONS Sotradecol (sodium tetradecyl sulfate injection) is contraindicated in previous hypersensitivity reactions to the drug; in acute superficial thrombophlebitis; valvular or deep vein incompetence; huge superficial veins with wide open communications to deeper veins; phlebitis migrans; acute cellulitis; … |
Source: FDA drug label (Sotradecol), Mylan Institutional LLC, effective August 17, 2021 (SPL set f1756c28-dcd2-4b49-be62-07ca20682018), via openFDA; the full label on DailyMed
What do FAERS reports show for tetradecyl hydrogen?
The FDA Adverse Event Reporting System holds 138 reports that list tetradecyl hydrogen among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 6 are coded as a death and 31 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
The most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026
What next?
- Tetradecyl hydrogen side effects
- the label's list beside FAERS reports
- Check an interaction
- what two or more labels say about each other